Go here to see the original:
Clearmind Medicine Partners with Dr. Gabor Maté to Discuss Alcohol Use Disorder and Trauma in a Special Virtual Event on February 3
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting
Erasca Presents Compelling Preclinical Data Supporting Clinical Development of Potentially Best-In-Class Programs ERAS-007, ERAS-601, and ERAS-3490 at…
Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
Gritstone Presentations at AACR Further Support Expertise in Neoantigen Vaccine Design and Delivery
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Strengthens Board of Directors with Appointment of Highly…
Turning Point Therapeutics Announces Positive Topline Data by Blinded Independent Central Review for Repotrectinib Across All ROS1-Positive NSCLC…
Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Pembrolizumab in Patients with…
Addex Therapeutics Completes Patient Enrollment for Dipraglurant Blepharospasm Phase 2 Clinical Study
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
See the original post here:
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
Basilea reports preclinical data on oncology drug candidates BAL0891, derazantinib and lisavanbulin at AACR Annual Meeting
Santhera Appoints Shabir Hasham as Chief Medical Officer and Member of the Executive Management Team
Catalyst Pharmaceuticals Announces Issuance of Mandate by the U.S. Court of Appeals for the 11th Circuit Directing the District Court Judge in…
Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary Artery Bypass Grafting
Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to…
ObsEva Announces Corporate Updates
See original here:
ObsEva Announces Corporate Updates
PAOG Publishes 2022 Strategic Update
See the rest here:
PAOG Publishes 2022 Strategic Update
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
See the article here:
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant
Cronos Group Provides Bi-Weekly MCTO Status Update
Read the original here:
Cronos Group Provides Bi-Weekly MCTO Status Update